Art

J-GLOBAL ID：201802211121476128   Reference number：18A1599068

Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST

PERCISTによる頭頸部扁平上皮癌患者における化学放射線療法に対する腫瘍反応の評価と予後予測

Author (12)： KATSUURA Takayuki (Hyogo Coll. of Medicine, Hyogo, JPN) ,  KITAJIMA Kazuhiro (Hyogo Coll. of Medicine, Hyogo, JPN) ,  FUJIWARA Masayuki (Hyogo Coll. of Medicine, Hyogo, JPN) ,  TERADA Tomonori (Hyogo Coll. of Medicine, Hyogo, JPN) ,  UWA Nobuhiro (Hyogo Coll. of Medicine, Hyogo, JPN) ,  NOGUCHI Kazuma (Hyogo Coll. of Medicine, Hyogo, JPN) ,  DOI Hiroshi (Kinki Univ. Fac. of Medicine, Osaka, JPN) ,  TAMAKI Yukihisa (Shimane Univ. School of Medicine, Shimane, JPN) ,  YOSHIDA Rika (Shimane Univ., Shimane, JPN) ,  TSUCHITANI Tatsuya (Hyogo Coll. of Medicine Coll. Hospital, Hyogo, JPN) ,  FUJITA Masahiro (Hyogo Coll. of Medicine, Hyogo, JPN) ,  YAMAKADO Koichiro (Hyogo Coll. of Medicine, Hyogo, JPN)
Material： Annals of Nuclear Medicine  (Ann Nucl Med)
Volume： 32  Issue： 7  Page： 453-462  Publication year： Aug. 2018 
JST Material Number： X0838A  ISSN： 0914-7187  CODEN： ANMEEX  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *clinical practice guideline ,...
Semi thesaurus term： *PERCIST ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1599068&from=J-GLOBAL&jstjournalNo=X0838A") }}

JST classification (2)： Radiodiagnosis  (GC04020K) ,  Diagnosis of tumors(=neoplasms)  (GE03020J)

Reference (16)：

• Ferlito A, Corry J, Silver CE, Shaha AR, Thomas Robbins K, Rinaldo A. Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck. 2010;32:253-61.
• Esteller E, Vega MC, Lopez M, Quer M, León X. Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy. Eur Arch Otorhinolaryngol. 2011;268:295-301.
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-47.
• Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S-50S.
• Odawara S, Kitajima K, Katsuura T, Kurahashi Y, Shinohara H, Yamakado K. Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0. Eur J Radiol. 2018;101:65-71.

Terms in the title (6)： 頭頸部扁平上皮癌 ,  患者 ,  化学放射線療法 ,  腫瘍 ,  評価 ,  予後予測